The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

CYTK FINANCIAL STATEMENTS

Cytokinetics Inc — balance sheet, income statement and cash flow trends

CYTKCytokinetics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-500 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue71 M $Gross Profit60.3 M $ · 85%Operating Income-704.6 M $ · -993%Pre-tax Income-894 M $ · -1260%Net Income to Owners-894 M $ · -1260%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue71 M $-17.2%
Gross Profit60.3 M $—
Operating Income-704.6 M $—
EBITDA-818.6 M $—
Net Income to Owners-894 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
01 B2 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets1.9 B
  • Current Liabilities181.4 M $9%
  • Long-term Liabilities1.9 B $91%

Key Figures

YoY change
Total Assets1.9 B $+57.0%
Total Liabilities2.1 B $+31.6%
Total Equity-173.5 M $—
Cash & ST Investments1.2 B $+35.8%
Total Debt1.3 B $+48.1%
Net Debt1 B $+29.6%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-750 M-500 M-250 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-1 B-500 M0-700.9 M $Operating-358.2 M $Investing1.2 B $Financing190.5 M $Net Change

Key Figures

YoY change
Operating Cash Flow-700.9 M $—
Capital Expenditures31.2 M $+130.1%
Free Cash Flow-732.1 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on CYTK

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.